BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30453756)

  • 1. Gene expression profiling in melanoma: past results and future potential.
    Knackstedt RW; Knackstedt T; Gastman B
    Future Oncol; 2019 Mar; 15(7):791-800. PubMed ID: 30453756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit.
    Grossman D; Okwundu N; Bartlett EK; Marchetti MA; Othus M; Coit DG; Hartman RI; Leachman SA; Berry EG; Korde L; Lee SJ; Bar-Eli M; Berwick M; Bowles T; Buchbinder EI; Burton EM; Chu EY; Curiel-Lewandrowski C; Curtis JA; Daud A; Deacon DC; Ferris LK; Gershenwald JE; Grossmann KF; Hu-Lieskovan S; Hyngstrom J; Jeter JM; Judson-Torres RL; Kendra KL; Kim CC; Kirkwood JM; Lawson DH; Leming PD; Long GV; Marghoob AA; Mehnert JM; Ming ME; Nelson KC; Polsky D; Scolyer RA; Smith EA; Sondak VK; Stark MS; Stein JA; Thompson JA; Thompson JF; Venna SS; Wei ML; Swetter SM
    JAMA Dermatol; 2020 Sep; 156(9):1004-1011. PubMed ID: 32725204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Level of Evidence Review for a Gene Expression Profile Test for Cutaneous Melanoma.
    Dubin DP; Dinehart SM; Farberg AS
    Am J Clin Dermatol; 2019 Dec; 20(6):763-770. PubMed ID: 31359351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Gene Expression Profile Tests for Prognosis in Patients With Localized Cutaneous Melanoma: A Systematic Review and Meta-analysis.
    Marchetti MA; Coit DG; Dusza SW; Yu A; McLean L; Hu Y; Nanda JK; Matsoukas K; Mancebo SE; Bartlett EK
    JAMA Dermatol; 2020 Sep; 156(9):953-962. PubMed ID: 32745161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating the melanoma 31-gene expression profile test with surgical oncology practice within national guideline and staging recommendations.
    Hyams DM; Covington KR; Johnson CE; Plasseraud KM; Cook RW
    Future Oncol; 2021 Feb; 17(5):517-527. PubMed ID: 33021104
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of Gene Expression Profiling on Decision-Making in Clinically Node Negative Melanoma Patients after Surgical Staging.
    Schuitevoerder D; Heath M; Cook RW; Covington KR; Fortino J; Leachman S; Vetto JT
    J Drugs Dermatol; 2018 Feb; 17(2):196-199. PubMed ID: 29462228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study.
    Dillon LD; McPhee M; Davidson RS; Quick AP; Martin B; Covington KR; Zolochevska O; Cook RW; Vetto JT; Jarell AD; Fleming MD
    Curr Med Res Opin; 2022 Aug; 38(8):1267-1274. PubMed ID: 35081854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Profiling in Cutaneous Melanoma.
    Ji AL; Bichakjian CK; Swetter SM
    J Natl Compr Canc Netw; 2016 Apr; 14(4):475-80. PubMed ID: 27059194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients.
    Greenhaw BN; Covington KR; Kurley SJ; Yeniay Y; Cao NA; Plasseraud KM; Cook RW; Hsueh EC; Gastman BR; Wei ML
    J Am Acad Dermatol; 2020 Sep; 83(3):745-753. PubMed ID: 32229276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management Decisions Made by Physician Assistants and Nurse Practitioners in Cutaneous Malignant Melanoma Patients: Impact of a 31-Gene Expression Profile Test.
    Mirsky R; Prado G; Svoboda R; Glazer A; Rigel D
    J Drugs Dermatol; 2018 Nov; 17(11):1220-1223. PubMed ID: 30500144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Affecting Dermatologists' Use of a 31-Gene Expression Profiling Test as an Adjunct for Predicting Metastatic Risk in Cutaneous Melanoma.
    Svoboda RM; Glazer AM; Farberg AS; Rigel DS
    J Drugs Dermatol; 2018 May; 17(5):544-547. PubMed ID: 29742186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.
    Zager JS; Gastman BR; Leachman S; Gonzalez RC; Fleming MD; Ferris LK; Ho J; Miller AR; Cook RW; Covington KR; Meldi-Plasseraud K; Middlebrook B; Kaminester LH; Greisinger A; Estrada SI; Pariser DM; Cranmer LD; Messina JL; Vetto JT; Wayne JD; Delman KA; Lawson DH; Gerami P
    BMC Cancer; 2018 Feb; 18(1):130. PubMed ID: 29402264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of gene expression profile testing as a prognostic tool in early-stage cutaneous melanoma - compelling but not ready for primetime.
    Christensen L; Scott J; Bordeaux J
    Melanoma Res; 2018 Dec; 28(6):652-654. PubMed ID: 30211811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing Genetic Expression Profiles in Melanoma Prognosis.
    Farberg AS; Glazer AM; Winkelmann RR; Rigel DS
    Dermatol Clin; 2017 Oct; 35(4):545-550. PubMed ID: 28886811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test.
    Hsueh EC; DeBloom JR; Lee J; Sussman JJ; Covington KR; Middlebrook B; Johnson C; Cook RW; Slingluff CL; McMasters KM
    J Hematol Oncol; 2017 Aug; 10(1):152. PubMed ID: 28851416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technological advances for the detection of melanoma: Advances in molecular techniques.
    Fried L; Tan A; Bajaj S; Liebman TN; Polsky D; Stein JA
    J Am Acad Dermatol; 2020 Oct; 83(4):996-1004. PubMed ID: 32360759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a 31-gene Expression Profiling Test for Cutaneous Melanoma on Dermatologists' Clinical Management Decisions.
    Farberg AS; Glazer AM; White R; Rigel DS
    J Drugs Dermatol; 2017 May; 16(5):428-431. PubMed ID: 28628677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnosis of melanoma-have we arrived?
    Bordelon JR; Grichnik JM
    Dermatol Ther; 2015; 28(6):405. PubMed ID: 26031627
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutation Testing and Adjuvant Systemic Therapy in Cutaneous Melanoma.
    Olszanski AJ
    J Natl Compr Canc Netw; 2019 May; 17(5.5):615-617. PubMed ID: 31117032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant melanoma: evolving practice management in an era of increasingly effective systemic therapies.
    Newcomer K; Robbins KJ; Perone J; Hinojosa FL; Chen D; Jones S; Kaufman CK; Weiser R; Fields RC; Tyler DS
    Curr Probl Surg; 2022 Jan; 59(1):101030. PubMed ID: 35033317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.